Apellis Pharmaceuticals
Apellis Pharmaceuticals Logo
About Apellis Pharmaceuticals
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for diseases with high unmet needs. The company pioneers targeted C3 therapies to treat complement-driven diseases across hematology, ophthalmology, and nephrology. Its approved products include EMPAVELI for paroxysmal nocturnal hemoglobinuria and SYFOVRE for geographic atrophy secondary to age-related macular degeneration. Apellis also has a pipeline of investigational therapies and collaborates with partners to advance innovative treatments for autoimmune and inflammatory conditions. Founded in 2009, Apellis is headquartered in Waltham, Massachusetts, and serves patients globally.
Address
100 Fifth Avenue,
Waltham, 02451
United States
Year founded
2009
Number of employees
700-800
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
